Fibrinolytics and Antifibrinolytics [electronic resource] /

Section I: Molecular Biology, Biochemistry, Physiology, and Pharmacology of the Plasminogen-Plasmin Enzyme System -- 1 The Fibrinolytic System and Thrombolytic Agents -- 2 Plasminogen and Streptokinase -- 3 Tissue-type Plasminogen Activator (tPA) -- 4 Urinary-type Plasminogen Activator (uPA) -- 5 The Inhibitors of the Fibrinolytic System -- 6 Assembly of the Plasminogen System on Cell Surfaces -- Section II: Clinical Use of Thrombolytic Agents -- In Acute Myocardial Infarction -- 7 Streptokinase and Anisoylated Lys-Plasminogen Streptokinase Activator Complex -- 8 Tissue-Type Plasminogen Activator (tPA) -- 9 Urokinase and Single-Chain Urokinase-Type Plasminogen Activator (Pro-urokinase) -- 10 Comparative Evaluations of tPA vs SK with Particular Reference to the GUSTO-I Trial -- 11 Conjunctive Therapy to Reduce the Occurrence of Coronary Reocclusion After Thrombolytic Treatment of AMI -- Thrombolytic Treatment of other Clinical Thromboembolic Conditions -- 12 New Concepts in Thrombolysis of Pulmonary Embolism -- 13 Deep Venous Thrombosis -- 14 Peripheral Arterial Occlusions -- 15 Thrombotic Cerebrovascular Disease -- Thrombolytic Agents in Development, Biochemistry, Pharmacology — Efficacy in Animal Experiments and First Clinical Trials -- 16 Staphylokinase -- 17 Desmodus rotundus (Common Vampire Bat) Salivary Plasminogen Activator -- 18 Thrombus-Targeting of Plasminogen Activators -- 19 The Hunt for the Ideal Thrombolytic Agent: Mutants of tPA and uPA, Chimera of Both Molecules, Fibrolase -- 20 Agents which Increase Synthesis and Release of Tissue-Type Plasminogen Activator -- Autifibrinolytic Agents -- 21 Structure, Pharmacology, and Clinical Use of Antifibrinolytic Agents.

Saved in:
Bibliographic Details
Main Authors: Bachmann, F. editor., SpringerLink (Online service)
Format: Texto biblioteca
Language:eng
Published: Berlin, Heidelberg : Springer Berlin Heidelberg : Imprint: Springer, 2001
Subjects:Medicine., Pharmacology., Cardiology., Biochemistry., Biomedicine., Pharmacology/Toxicology., Biochemistry, general.,
Online Access:http://dx.doi.org/10.1007/978-3-642-56637-0
Tags: Add Tag
No Tags, Be the first to tag this record!
id KOHA-OAI-TEST:213482
record_format koha
spelling KOHA-OAI-TEST:2134822018-07-30T23:47:04ZFibrinolytics and Antifibrinolytics [electronic resource] / Bachmann, F. editor. SpringerLink (Online service) textBerlin, Heidelberg : Springer Berlin Heidelberg : Imprint: Springer,2001.engSection I: Molecular Biology, Biochemistry, Physiology, and Pharmacology of the Plasminogen-Plasmin Enzyme System -- 1 The Fibrinolytic System and Thrombolytic Agents -- 2 Plasminogen and Streptokinase -- 3 Tissue-type Plasminogen Activator (tPA) -- 4 Urinary-type Plasminogen Activator (uPA) -- 5 The Inhibitors of the Fibrinolytic System -- 6 Assembly of the Plasminogen System on Cell Surfaces -- Section II: Clinical Use of Thrombolytic Agents -- In Acute Myocardial Infarction -- 7 Streptokinase and Anisoylated Lys-Plasminogen Streptokinase Activator Complex -- 8 Tissue-Type Plasminogen Activator (tPA) -- 9 Urokinase and Single-Chain Urokinase-Type Plasminogen Activator (Pro-urokinase) -- 10 Comparative Evaluations of tPA vs SK with Particular Reference to the GUSTO-I Trial -- 11 Conjunctive Therapy to Reduce the Occurrence of Coronary Reocclusion After Thrombolytic Treatment of AMI -- Thrombolytic Treatment of other Clinical Thromboembolic Conditions -- 12 New Concepts in Thrombolysis of Pulmonary Embolism -- 13 Deep Venous Thrombosis -- 14 Peripheral Arterial Occlusions -- 15 Thrombotic Cerebrovascular Disease -- Thrombolytic Agents in Development, Biochemistry, Pharmacology — Efficacy in Animal Experiments and First Clinical Trials -- 16 Staphylokinase -- 17 Desmodus rotundus (Common Vampire Bat) Salivary Plasminogen Activator -- 18 Thrombus-Targeting of Plasminogen Activators -- 19 The Hunt for the Ideal Thrombolytic Agent: Mutants of tPA and uPA, Chimera of Both Molecules, Fibrolase -- 20 Agents which Increase Synthesis and Release of Tissue-Type Plasminogen Activator -- Autifibrinolytic Agents -- 21 Structure, Pharmacology, and Clinical Use of Antifibrinolytic Agents.Medicine.Pharmacology.Cardiology.Biochemistry.Biomedicine.Pharmacology/Toxicology.Biochemistry, general.Cardiology.Springer eBookshttp://dx.doi.org/10.1007/978-3-642-56637-0URN:ISBN:9783642566370
institution COLPOS
collection Koha
country México
countrycode MX
component Bibliográfico
access En linea
En linea
databasecode cat-colpos
tag biblioteca
region America del Norte
libraryname Departamento de documentación y biblioteca de COLPOS
language eng
topic Medicine.
Pharmacology.
Cardiology.
Biochemistry.
Biomedicine.
Pharmacology/Toxicology.
Biochemistry, general.
Cardiology.
Medicine.
Pharmacology.
Cardiology.
Biochemistry.
Biomedicine.
Pharmacology/Toxicology.
Biochemistry, general.
Cardiology.
spellingShingle Medicine.
Pharmacology.
Cardiology.
Biochemistry.
Biomedicine.
Pharmacology/Toxicology.
Biochemistry, general.
Cardiology.
Medicine.
Pharmacology.
Cardiology.
Biochemistry.
Biomedicine.
Pharmacology/Toxicology.
Biochemistry, general.
Cardiology.
Bachmann, F. editor.
SpringerLink (Online service)
Fibrinolytics and Antifibrinolytics [electronic resource] /
description Section I: Molecular Biology, Biochemistry, Physiology, and Pharmacology of the Plasminogen-Plasmin Enzyme System -- 1 The Fibrinolytic System and Thrombolytic Agents -- 2 Plasminogen and Streptokinase -- 3 Tissue-type Plasminogen Activator (tPA) -- 4 Urinary-type Plasminogen Activator (uPA) -- 5 The Inhibitors of the Fibrinolytic System -- 6 Assembly of the Plasminogen System on Cell Surfaces -- Section II: Clinical Use of Thrombolytic Agents -- In Acute Myocardial Infarction -- 7 Streptokinase and Anisoylated Lys-Plasminogen Streptokinase Activator Complex -- 8 Tissue-Type Plasminogen Activator (tPA) -- 9 Urokinase and Single-Chain Urokinase-Type Plasminogen Activator (Pro-urokinase) -- 10 Comparative Evaluations of tPA vs SK with Particular Reference to the GUSTO-I Trial -- 11 Conjunctive Therapy to Reduce the Occurrence of Coronary Reocclusion After Thrombolytic Treatment of AMI -- Thrombolytic Treatment of other Clinical Thromboembolic Conditions -- 12 New Concepts in Thrombolysis of Pulmonary Embolism -- 13 Deep Venous Thrombosis -- 14 Peripheral Arterial Occlusions -- 15 Thrombotic Cerebrovascular Disease -- Thrombolytic Agents in Development, Biochemistry, Pharmacology — Efficacy in Animal Experiments and First Clinical Trials -- 16 Staphylokinase -- 17 Desmodus rotundus (Common Vampire Bat) Salivary Plasminogen Activator -- 18 Thrombus-Targeting of Plasminogen Activators -- 19 The Hunt for the Ideal Thrombolytic Agent: Mutants of tPA and uPA, Chimera of Both Molecules, Fibrolase -- 20 Agents which Increase Synthesis and Release of Tissue-Type Plasminogen Activator -- Autifibrinolytic Agents -- 21 Structure, Pharmacology, and Clinical Use of Antifibrinolytic Agents.
format Texto
topic_facet Medicine.
Pharmacology.
Cardiology.
Biochemistry.
Biomedicine.
Pharmacology/Toxicology.
Biochemistry, general.
Cardiology.
author Bachmann, F. editor.
SpringerLink (Online service)
author_facet Bachmann, F. editor.
SpringerLink (Online service)
author_sort Bachmann, F. editor.
title Fibrinolytics and Antifibrinolytics [electronic resource] /
title_short Fibrinolytics and Antifibrinolytics [electronic resource] /
title_full Fibrinolytics and Antifibrinolytics [electronic resource] /
title_fullStr Fibrinolytics and Antifibrinolytics [electronic resource] /
title_full_unstemmed Fibrinolytics and Antifibrinolytics [electronic resource] /
title_sort fibrinolytics and antifibrinolytics [electronic resource] /
publisher Berlin, Heidelberg : Springer Berlin Heidelberg : Imprint: Springer,
publishDate 2001
url http://dx.doi.org/10.1007/978-3-642-56637-0
work_keys_str_mv AT bachmannfeditor fibrinolyticsandantifibrinolyticselectronicresource
AT springerlinkonlineservice fibrinolyticsandantifibrinolyticselectronicresource
_version_ 1756269211365146624